http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201200359-A1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201200359-A1
titleOfInvention PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
abstract The invention relates to the field of pharmaceutical industry and medicine. The present invention is the creation of an effective pharmaceutical composition with neuroprotective, antiamnesic, antioxidant, antihypoxic, anti-ischemic activity. The problem is solved due to the fact that the pharmaceutical composition contains 2-ethyl-6-methyl-3-hydroxypyridine succinate, peptide Met-Glu-His-Phe-Pro-Gly-Pro and differs from the prototype in that it additionally contains minerals zinc, magnesium, iron. In addition, in the pharmaceutical composition of the carbon isotopes replaced by carbon isotopes. The technical results of the invention are to increase the rate of onset of therapeutic effect, increase therapeutic effect without increasing the concentration of 2-ethyl-6-methyl-3-hydroxypyridine succinate and peptide Met-Glu-His-Phe-Pro-Gly-Pro, increasing stability during the shelf life .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2564008-C2
priorityDate 2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77134415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428593666

Total number of triples: 28.